Qube Research & Technologies (QRT)’s DexCom DXCM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.15M	Sell	34,300 -18,500	-35%	-$1.29M	﹤0.01%	2130
2025 Q4	$3.5M	Buy	52,800 +19,400	+58%	+$1.25M	﹤0.01%	1968
2025 Q3	$2.25M	Sell	33,400 -56,000	-63%	-$4.43M	﹤0.01%	2187
2025 Q2	$7.8M	Buy	89,400 +33,900	+61%	+$2.66M	0.01%	1449
2025 Q1	$3.79M	Buy	55,500 +8,900	+19%	+$726K	﹤0.01%	1674
2024 Q4	$3.62M	Sell	46,600 -12,300	-21%	-$911K	﹤0.01%	1642
2024 Q3	$3.95M	Buy	58,900 +56,700	+2,577%	+$4.66M	0.01%	1503
2024 Q2	$249K	Buy	+2,200	New	+$278K	﹤0.01%	2370
2023 Q4	–	Sell	-5,800	Closed	-$541K	–	4434
2023 Q3	$541K	Buy	+5,800	New	+$654K	﹤0.01%	1999

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DXCM Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of DexCom (DXCM) in Q1 2026, closing a stake of 151,947 shares — an estimated $10.6M sold.

Qube Research & Technologies (QRT) first reported a position in DXCM in Q2 2020 and held it in 16 quarters. The position peaked at $142M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Qube Research & Technologies (QRT) reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 151,947 DexCom shares in Q1 2026, an estimated $10.6M.
Qube Research & Technologies (QRT) first reported a position in DexCom in Q2 2020 and held it in 16 quarters.
Qube Research & Technologies (QRT)'s DexCom position peaked at $142M in Q2 2025.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.